Clinical trials recruiting for Lung Neoplasm Malignant
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Oregon | 2 |
| Alabama | 1 |
| California | 1 |
| Colorado | 1 |
| Florida | 1 |
| Illinois | 1 |
| Maryland | 1 |
| New York | 1 |
| Texas | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Benefit of Spectral Information in Patients Suspected for Lung Cancer
- Confocal Laser Endomicroscopy VERification
- Enhanced COPD Management in Suspected Lung Cancer Patients
- Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
- MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
- Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
- Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
Related conditions
Trials recruiting for Lung Neoplasm Malignant often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Neoplasm Malignant trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.